Jamison / Waite Venture Investing in Science

1. Auflage 2017
ISBN: 978-0-231-54470-2
Verlag: De Gruyter
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 272 Seiten

Reihe: Columbia Business School Publishing

Over the past decade, software companies have increasingly monopolized the flow of venture capital, starving support for scientific research and its transformative discoveries. New medicines, cheaper and faster personal computers, and other life-changing developments all stem from investment in science. In the past, these funds led to steam engines, light bulbs, microprocessors, 3D printers, and even the Internet. In Venture Investing in Science, the venture capitalist Douglas W. Jamison and the investment author Stephen R. Waite directly link financial support to revolutionary advancements in physics, computers, chemistry, and biology and make a passionate case for continued investing in science to meet the global challenges of our time.

Clean air and water, cures for intractable diseases, greener public transportation, cheaper and faster communication technologies—these are some of the rich opportunities awaiting venture capital investment today. Jamison and Waite focus on how early-stage companies specializing in commercializing transformative technologies based on deep science have been shunned by venture capitalists, and how the development of such companies have been hampered by structural changes in capital markets and government regulation over the past decade. The authors argue that reinvigorating science-based technological innovation is crucial to reactivating the economic dynamism that lifts living standards and fuels prosperity over time.

Autoren/Hrsg.

Jamison, Douglas

Waite, Stephen

Fachgebiete

• Wirtschaftswissenschaften Finanzsektor & Finanzdienstleistungen Anlagen & Wertpapiere
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Naturwissenschaften, Technik, Medizin

Über Autor(innen)

Douglas W. Jamison is the chairman and CEO of HALE.life, a privately held precision health and medicine operating company in which Harris & Harris Group is an investor. Previously he was chairman and CEO of Harris & Harris Group, a publicly traded company that makes early-stage venture capital investments in science-based companies.

Stephen R. Waite works as a strategic advisor and investment manager. He is the author of Quantum Investing (2003) and coauthor of Boomernomics (1998).